The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-Methyl-4-(8-(1-methyl-1H-tetrazol-5-yl)-10,11-dihydrodibenzo[b,f]thiepin-10-yl)piperazine ID: ALA1259217
PubChem CID: 49781233
Max Phase: Preclinical
Molecular Formula: C21H24N6S
Molecular Weight: 392.53
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnnn4C)cc32)CC1
Standard InChI: InChI=1S/C21H24N6S/c1-25-9-11-27(12-10-25)18-14-15-5-3-4-6-19(15)28-20-8-7-16(13-17(18)20)21-22-23-24-26(21)2/h3-8,13,18H,9-12,14H2,1-2H3
Standard InChI Key: NHCPMAKOQMYGRA-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
-1.3616 0.9439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5574 0.7427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3971 -0.9167 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.0152 -0.3926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0258 0.4073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7226 0.7964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4094 0.3867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3949 -0.4162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6976 -0.8016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2245 -0.0046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6189 -0.7672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1559 -1.4879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7015 -1.4472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0937 -0.6798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6284 0.0377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5394 1.7495 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9276 2.3036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1027 3.1061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8883 3.3591 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4992 2.8031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3244 1.9941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0631 4.1680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1304 0.7876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1210 1.6089 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9010 1.8777 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.3976 1.2189 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9244 0.5431 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1922 -0.2373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
13 14 1 0
11 3 1 0
14 15 2 0
15 10 1 0
6 7 2 0
1 16 1 0
16 17 1 0
3 4 1 0
7 8 1 0
2 10 1 0
8 9 2 0
9 4 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
19 22 1 0
1 5 1 0
7 23 1 0
23 24 2 0
10 11 2 0
4 5 2 0
11 12 1 0
1 2 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 23 1 0
12 13 2 0
27 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 392.53Molecular Weight (Monoisotopic): 392.1783AlogP: 2.87#Rotatable Bonds: 2Polar Surface Area: 50.08Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.98CX LogP: 3.45CX LogD: 2.77Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.67Np Likeness Score: -1.23
References 1. Kristensen JL, Püschl A, Jensen M, Risgaard R, Christoffersen CT, Bang-Andersen B, Balle T.. (2010) Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for α(1)-adrenoceptors., 53 (19): [PMID:20857909 ] [10.1021/jm100652h ]